Cilostazol
Noclaud, which contains the active ingredient cilostazol, belongs to a group of medicines called phosphodiesterase type 3 inhibitors. It has various effects, including the dilation of certain blood vessels and the reduction of the activity of blood clotting (aggregation) of certain blood cells, called platelets, within blood vessels.
Noclaud has been prescribed to treat "intermittent claudication". Intermittent claudication is a cramp-like pain in the legs that occurs during walking, which is caused by insufficient blood flow to the legs. Noclaud increases the distance that a patient can walk without pain by improving blood circulation in the legs.
Cilostazol is only recommended for patients in whom lifestyle modifications (including smoking cessation and increased exercise intensity) and other appropriate interventions have not sufficiently alleviated symptoms. It is essential that patients continue to apply lifestyle modifications during cilostazol treatment.
Before taking Noclaud, discuss it with your doctor or pharmacist
During treatment with Noclaud
Noclaud is not intended for use in children.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, and about any medicines you plan to take.
In particular, inform your doctor about taking certain medicines that are usually used to treat pain and/or inflammation of muscles or joints and medicines that reduce blood clotting. These include:
If you are taking such medicines together with Noclaud, your doctor may perform certain routine blood tests.
Some medicines taken at the same time as Noclaud may interfere with its effects or increase the risk of side effects. Noclaud may also affect other medicines. Before taking Noclaud, tell your doctor about taking:
In case of doubt whether the above applies to the medicines you are taking, consult your doctor or pharmacist.
Before taking Noclaud, inform your doctor if you are taking medicines for high blood pressure, as Noclaud may cause additional blood pressure lowering effects. If blood pressure drops too low, it may lead to rapid heartbeat. These medicines include:
It may be possible to continue taking these medicines together with Noclaud, and your doctor will be able to decide what treatment is appropriate for you.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Noclaud MUST NOTbe taken during pregnancy.
Noclaud is NOT RECOMMENDEDfor use in breastfeeding mothers.
Noclaud may cause dizziness. If you experience dizziness after taking Noclaud, DO NOTdrive, DO NOTuse tools or machines. Inform your doctor or pharmacist.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Some benefits of taking Noclaud may be noticeable after 4-12 weeks of treatment.
Your doctor will assess the effectiveness after 3 months of treatment and may recommend stopping cilostazol treatment if the therapy is not effective enough.
Noclaud is not intended for use in children.
If you have taken more tablets than prescribed, you may experience symptoms such as severe headache, diarrhea, low blood pressure, and irregular heartbeat.
If you have taken more tablets than prescribed, contact your doctor or local hospital immediately. Remember to take the package with you to show which medicine you have taken.
There is no need to worry if you miss a dose. Wait and take the next dose at the right time, and then continue taking the medicine as directed. DO NOTtake a double dose to make up for a missed tablet.
If you stop taking Noclaud, the pain in your legs may return or worsen. Therefore, only stop taking Noclaud if you experience side effects that require urgent medical attention (see section 4) or on the advice of your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, you may need urgent medical attention. Stop taking Noclaud and contact your doctor or go to the nearest hospital immediately.
You should also tell your doctor immediately if you experience fever or sore throat.
It may be necessary to perform certain blood tests, and your doctor will decide on further treatment.
Very common side effects(may affect more than 1 in 10 people)
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
In people with diabetes, there may be a higher risk of bleeding in the eye.
Rare side effects(may affect up to 1 in 1000 people)
The following side effects have been reported during treatment with cilostazol, but the frequency is unknown(frequency cannot be estimated from the available data);
If any of the side effects get worse, tell your doctor or pharmacist.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicinal product does not require any special storage conditions.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Do not use this medicine if you notice any visible signs of deterioration (e.g. discoloration).
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Appearance:
Odorless or almost odorless, white or almost white, round, flat tablets with beveled edges. The tablets have a stylized letter E and the number 602 embossed on one side, and no markings on the other side.
Packaging:
28 x (2 x 14), 56 x (4 x 14), or 98 (7 x 14) tablets in PVC/PVDC/Aluminum blisters in a cardboard box with a patient information leaflet.
Not all pack sizes may be marketed.
EGIS Pharmaceuticals PLC
Keresztúri út 30-38
1106 Budapest,
Hungary
EGIS Pharmaceuticals PLC
Bökényföldi út 118-120.
1165 Budapest,
Hungary
Hungary Noclaud 100 mg tablet
Czech Republic Noclaud
Latvia Sollazon 100 mg tablets
Lithuania Sollazon 100 mg tabletės
Poland Noclaud
Date of last revision of the leaflet: 03.03.2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.